EHRA 22: Results From the POWER-FAST III Trial | Dr José Merino

EHRA 22: EAST-AFNET 4 in Clinical Practice | Dr Paulus KirchhofПодробнее

ACC 22: Results from the POISE-3 Trial | Dr Philip J DevereauxПодробнее

EHRA 22: Precision Medicine Approach to AF | Dr Luigi DiBiaseПодробнее

ACC 22: Results from a sub-study of the POISE-3 Trial | Dr Maura MarcucciПодробнее

MP0533, a CD3-engaging DARPin, in R/R AML or MDS/AML: preliminary results of a Phase I/IIa trialПодробнее

EHRA 22: Early Rhythm Control Therapy For AF Patients Found To Reduce Cardiovascular OutcomesПодробнее

Jose Merino, EHRA 2018 - Hot Topics on Complex AblationПодробнее

EHRA 22: Real-world Data on S-ICD in Heart Failure Patients | Dr Marco SchiavoneПодробнее

ACC 22: Results from the PACIFIC AF Trial | Dr Manesh PatelПодробнее

ESC 2022: 3 Trials That Will Change Your Practice With Interventionalist, Dr Mirvat AlasnagПодробнее

What you need to know about your ESR lab resultПодробнее

Susceptibility Testing for Piperacillin-Tazobactam: a Trial and a Lot of ErrorsПодробнее

AHA 22 Late-Breaker Discussion: The PRECISE TrialПодробнее

Jose Merino, Heart Rhythm 2019 – Oesophageal Damage During Atrial Fibrillation AblationПодробнее

MILESTONE trial results: MRD response-adapted deferral of autoSCT in newly diagnosed myelomaПодробнее

ACC 22: Results From the Chocolate-Touch Study | Dr Mehdi ShishehborПодробнее

High Power (50W) Short Duration procedures of AF ablation with commercially available cathetersПодробнее

VEITH 22: Findings From the BEST-CLI Trial | Dr Farber, Dr Rosenfield & Dr MenardПодробнее